For an industry full of brilliant scientists, pharmaceutical companies are slow to adopt evidence based sales methodologies. Here’s why. Pharma companies spend impressive amounts of money on the clinical development of drugs to bring them to market. A significant portion of this investment is in clinical trials where very smart people design studies that tell us important things about a drug’s efficacy and safety. Rigorous focus on excellence in science, trial design, and